Startup News:Instacart goes public, while Klaviyo, Turo, and Neumora provide fresh details about IPO plans
Startup News:
Trading
Data
Solutions
Insights
About
Altos Labs, based in San Francisco, was founded in 2021 by Hans Bishop and Richard Klausner. Hal Barron is the company’s CEO. The biotech company is focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease, injuries, and disabilities that can occur through life.
Scientists say that this rejuvenation process holds great potential to treat vision loss, spinal cord injuries, brain injuries and other age-related bodily degeneration. In a 2018 study, Salk Institute biochemist Juan Carlos Izpisua Belmonte declared this process "the elixir of life" and said that "aging is not an irreversible process."
Among the leading investors are Amazon founder Jeff Bezos and ARCH Venture Partners, along with other wealthy individuals from Silicon Valley and the Persian Gulf. Remarkably, the company has raised $3 billion in funding. The company, which has a last known valuation of $3.67 billion, has not officially endorsed a plan to participate in an IPO.
Altos Labs does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Altos Labs will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 3/25/2022 | Series B | $819.55MM raised | $XXX.XX | $XXX.XX |
| 9/4/2021 | Series A | $336.39MM raised | $XXX.XX | $XXX.XX |
Altos Labs is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Altos Labs pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Altos Labs is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Jeff Bezos invested in Altos Labs in 2022.
Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.
The CEO of Altos Labs is Hal Barron.
